Research Grants

The Osteosarcoma Institute (OSI) was established to develop a comprehensive strategy that will lead to major improvement in the life expectancy of patients with relapsed and metastatic osteosarcoma.

To further this goal, the OSI is seeking Letters of Intent (LOI) for grant proposals to conduct clinical, correlative, and translational studies. This year the foundation offers a new pilot grant program is for bold new ideas that may fall within any part of a drug development path, and that seek to deliver curative outcomes to patients with osteosarcoma.

Funding: $250,000 per year / Pilot grants $125,000

Duration: 2 years/ Pilot grants 1 year

Research Authority due dates: 8.11.23

LOI  (required) due date: 15.11.223

Full proposal due date: 12.4.24